Company Overview and News
SYDNEY, Australia, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Australian-based lithium-boron mine developer Global Geoscience Limited (“Global” or the “Company”) (ASX: GSC) today announced the production of premium quality boric acid from the Rhyolite Ridge Lithium-Boron Project (“Project”) in Nevada, USA. The boric acid contains very low levels of impurities and was produced using a conventional flowsheet developed for the Rhyolite Ridge Pre-Feasibility Study (“PFS”).
GSC RIO RIO MALRY AMFW WG MIN AMFW RTPPF RIO AMCBF RTNTF MALRF
2018-08-27 seekingalpha - 1
Lithium market news - China’s lithium price decline is not the full picture to an industry surging.
LIT CXO SAV LAXXF LIACF AGY PFFOF WML POR ABEPF SQM MLNLF AVLNF AIS.H KDR SYA STLHF WMLLF LNRDY ADV ABE NGZ LMMFF GXY LRS PLU MNIKF HNR AMLM AVL ALB DMNXF MALRY MIN ARYMF LKE DDXFF MGXMF PLUUF DJIFF PSC EMH CRECF ERPNF PLS GSC NNO LTMCF DJI PDDTF NTTHF NNOMF AVLIF MALRF ORE AVZ AJM
Diggers and Dealers Mining Forum 2018 has begun and will welcome its first battery mineral plays to the stage this afternoon, as punters and companies alike consider the prospects for graphite, lithium, nickel and cobalt, among others.
PLS GSC MCRZF PILBF SGQ MCR AU IGO IIDDY AULGF MCRZY AGG WNARF WSA
NORTH SYDNEY, Australia, Aug. 03, 2018 (GLOBE NEWSWIRE) -- Australian-based lithium-boron mine developer Global Geoscience Limited (“Global” or the “Company”) (ASX: GSC) today announced results from ongoing mining studies at the Rhyolite Ridge lithium-boron deposit in Nevada, USA. These studies show potential for higher cashflow in the early years of mining by targeting mineralisation with higher lithium grades.
GSC MALRY MALRF MIN
Global Geoscience Ltd (ASX:GSC) has progressed a pre-feasibility study at its Rhyolite Ridge Lithium-Boron Project in Nevada, USA, confirming the deposit can support a mine life of at least 30 years.
Global Geoscience is focused on developing its 100%-owned Rhyolite Ridge Lithium-Boron Project in Nevada, USA. Rhyolite Ridge is located close to existing infrastructure in southern Nevada, USA. The Project lies 25km west of Albermarle’s Silver Peak lithium mine and 340km from Reno.
GSC AMFW AMCBF MALRY AMFW MALRF WG MIN
2018-07-26 seekingalpha - 1
Lithium spot and contract price news - China spot prices slightly down in July, global contract prices remain strong.
LIT CXO SAV LAXXF LIACF PFFOF WML POR ABEPF SQM MLNLF AVLNF AIS.H SYA STLHF WMLLF LNRDY ABE NGZ LMMFF GXY LRS PLU MNIKF HNR AMLM AVL ALB DMNXF MALRY MIN LKE DDXFF MGXMF PLUUF DJIFF PSC EMH CRECF ERPNF PLS GSC NNO LTMCF DJI PDDTF NTTHF NNOMF AVLIF BCLMF MALRF ORE AVZ AJM
NORTH SYDNEY, Australia, June 13, 2018 (GLOBE NEWSWIRE) -- Global Geoscience Limited (“Global” or the “Company”) (ASX:GSC) is pleased to announce that the Company has completed the underwritten institutional placement (Placement) announced on 13 June 2018. The Placement was heavily oversubscribed, reflecting strong support for the Company from a combination of existing shareholders and new high-quality institutional investors, driven by ongoing interest in Global's 100% owned Rhyolite Ridge Lithium-Boron Project in Nevada, USA.
Sydney-based Global Geoscience has raised $53 million in a placement to advance the company’s Rhyolite Ridge lithium-boron project in Nevada.
Global Geoscience Ltd (ASX:GSC) has secured $53 million through a fully underwritten share placement priced at 41 cents per share.
NORTH SYDNEY, Australia, June 12, 2018 (GLOBE NEWSWIRE) -- Global Geoscience Limited (“Global” or the “Company”) (ASX:GSC) is pleased to announce that the Company is conducting a fully underwritten institutional placement (Placement) to professional and sophisticated investors to raise A$53 million.
NORTH SYDNEY, Australia, June 06, 2018 (GLOBE NEWSWIRE) -- Australian-based lithium-boron mine developer Global Geoscience Limited (“Global” or the “Company”) (ASX:GSC) today announced the appointments of Michael Le Page and Yoshio Nagai as Commercial Director and Sales & Business Development Director, respectively, to lead the global sales, marketing and supply chain aspects of the Company's flagship Rhyolite Ridge Lithium-Boron Project in Nevada, USA.
GSC RTPPF RIO RIO RIO RTNTF
Global Geoscience Ltd (ASX:GSC) has unveiled additional details from its ongoing pre-feasibility study (PFS) of the 100%-owned Rhyolite Ridge Lithium-Boron Project in Nevada, US.
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
2018-09-18 - Asif
Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...
2018-09-18 - Asif
Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...
Silicon Investor Message Boards
This table lists all message boards related to ASX:GSC / GLOBAL GEOSCIENCE LIMITED on message board site Silicon Investor.